Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 1, 2003, Pages 46-49

  Nemoto, Kenji ^a   Matsushita, Haruo ^a   Ogawa, Yoshihiro ^a   Takeda, Ken ^a   Takahashi, Chiaki ^a   Britton, Keith R ^a   Takai, Yoshihiro ^a   Miyazaki, Shukichi ^a   Miyata, Tsuyoshi ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 FU; Chemotherapy; Esophageal cancer; Nedaplatin; Radiation therapy

Indexed keywords

COLONY STIMULATING FACTOR; FLUOROURACIL; GRANISETRON; NEDAPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS HEMORRHAGE; FEMALE; HUMAN; LEUKOPENIA; MALE; NAUSEA; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; RADIATION DOSE; RECURRENT CANCER; SURVIVAL RATE; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; TRACHEOESOPHAGEAL FISTULA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PILOT PROJECTS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0037318945     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200302000-00010     Document Type: Article

References (24)

1. Okawa T, Kita M, Tanaka M, et al. Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1989;17:49-54.
2. De-Ren S. Ten-year follow-up of esophageal cancer treated by radical radiation therapy. Analysis of 869 patients. Int J Radiat Oncol Biol Phys 1989;16:329-334.
3. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
4. Smith TJ, Ryan LM, Douglass HO, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:269-276.
5. Jeremic B, Shibamoto Y, Acimovic L, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998;40:1061-1066.
6. Hsu CH, Yeh KH, Lui LT, et al. Concurrent chemoradiotherapy for locally advanced esophageal cancer-a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil. Anticancer Res 1999;19:4463-4467.
7. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-2921.
8. Murakami M, Kuroda Y, Nakajima T, et al. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:277-284.
9. Sasaki Y, Amano T, Morita M, et al. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res 1991;51:1472-1477.
10. Uchida N, Takeda Y, Hojo K, et al. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model. Eur J Cancer 1998;34:1796-1801.
11. Yoshioka T, Gamoh M, Shineha R, et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers. Intern Med 1999;38:844-848.
12. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-214.
13. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
14. Shiratori O, Kanai H, Uchida N, et al. Antitumor activity of 254-S, a platinum complex, in rodents. In: Ishigami J, ed. Recent advances in chemotherapy, anticancer Sect. 1. Tokyo: University of Tokyo Press, 1985:635-636.
15. Totani T, Aono K, Adachi Y, et al. Bidentate hydroxycarboxylic acid platinum (II) complexes with antitumor activity. In: Nicolini M, ed. Platinum and other metal coordination compounds in cancer chemotherapy. Boston: Martinus Nijhoff Publishing, 1988:744-748.
16. Sasaki Y, Amano T, Morita M, et al. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res 1991;51:1472-1477.
17. Fukuda M, Shinkai T, Eguchi K, et al. Phase II study of (glycolaate-0,0′) diammineplatinum (II), a novel platinum complex, in the treatment of non-small-cell lung cancer. Cancer Chemother Pharmacol 1990;26:393-396.
18. Akaza H, Togashi M, Nishio Y, et al. Phase II study of cisdiammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. Cancer Chemother Pharmacol 1992;31:187-192.
19. Takeda Y, Kasai H, Uchida N, et al. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts. Anticancer Res 1999;19:4059-4064.
20. Yamanaka H, Motohiro T, Michiura T, et al. Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer. Jpn J Thorac Cardiovasc Surg 1998;46:943-948.
21. Dubben HH. Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours. Radiother Oncol 1994;32:197-200.
22. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
23. Nishimura Y, Ono K, Tsutsui K, et al. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 1995;30:1099-1105.
24. Kajanti M, Kaleta R, Kankaanranta L, et al. Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1995;32:1017-1023.